Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.00% is 100% below its 5-year average of 2.18%, near the low end of its 5-year range (0.00%–17.69%).
As of the fiscal period ended Tuesday, June 30, 2026. 100.00% below its 12-month average of 1.98%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
DEBT TO ASSETS RATIO
0.00%
DEBT TO ASSETS RATIO AVG TTM
1.98%
DEBT TO ASSETS RATIO AVG 3Y
2.27%
DEBT TO ASSETS RATIO AVG 5Y
2.18%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-100.00%
CURRENT VS 3Y AVG
-100.00%
CURRENT VS 5Y AVG
-100.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
CNS Pharmaceuticals, Inc.
Market Cap
$7.75M
Debt to Assets Ratio
0.00%
TTM Avg
1.98%
3Y Avg
2.27%
5Y Avg
2.18%
Market Cap
$7.67M
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.64M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.87M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.62M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CNS Pharmaceuticals, Inc. (CNSP) | $7.75M | 0.00% | 1.98% | 2.27% | 2.18% |
| ENDRA Life Sciences Inc. (NDRA)vs › | $7.67M | 0.05% | N/A | N/A | N/A |
| Mangoceuticals, Inc. (MGRX)vs › | $7.64M | 0.02% | N/A | N/A | N/A |
| Aprea Therapeutics, Inc. (APRE)vs › | $7.87M | 0.00% | N/A | N/A | N/A |
| Quince Therapeutics, Inc. (QNCX)vs › | $7.62M | 0.00% | N/A | N/A | N/A |
| Traws Pharma, Inc. (TRAW)vs › | $7.92M | 0.00% | N/A | N/A | N/A |
| GT Biopharma, Inc. (GTBP)vs › | $8.04M | 0.00% | N/A | N/A | N/A |
| DataMEDS AI, Inc. (MEDS)vs › | $8.05M | 1.00% | N/A | N/A | N/A |
| HeartSciences Inc. (HSCS)vs › | $8.14M | 1.07% | N/A | N/A | N/A |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.31M | 0.00% | N/A | N/A | N/A |
Debt/Assets
0.0%
Debt/Equity
0.00
Current Ratio
5.86
Interest Coverage
-1049.7x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 4.99% |
| 2025-12-31 | 3.81% |
| 2025-09-30 | 0.26% |
| 2025-06-30 | 0.84% |
| 2025-03-31 | 1.53% |
| 2024-12-31 | 3.75% |
| 2024-09-30 | 0.42% |
| 2024-06-30 | 4.99% |
| 2024-03-31 | 12.83% |
| 2023-12-31 | 17.69% |
| 2023-09-30 | 1.80% |
| 2023-06-30 | 2.58% |
| 2023-03-31 | 3.90% |
| 2022-12-31 | 3.14% |
| 2022-09-30 | 0.41% |
| 2022-06-30 | 1.26% |
| 2022-03-31 | 1.72% |
| 2021-12-31 | 4.43% |
| 2021-09-30 | 0.39% |
| 2021-06-30 | 1.25% |
| 2021-03-31 | 2.35% |
| 2020-12-31 | 2.77% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 21.46% |
| 2019-06-30 | 18.27% |
| 2019-03-31 | 52.63% |
| 2018-12-31 | 46.38% |
| 2018-06-30 | 40.88% |
| 2018-03-31 | 48.90% |
